GELS NASDAQ
Gelteq Limited Ordinary Shares
1W: -4.5%
1M: -25.5%
3M: -12.8%
YTD: -37.8%
1Y: -59.6%
$0.52
-0.02 (-3.96%)
Weekly Expected Move ±20.8%
$0
$0
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$4.8M
52W Range0.387-2.01
Volume70,194
Avg Volume4,186,245
Beta-0.40
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEONathan Jacob Givoni
Employees18
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2024-10-29
Websitegelteq.com
Monash Innovation Labs, G.60, 22 Alliance Lane
Clayton, VIC 3800
AU
Clayton, VIC 3800
AU
61 3 9087 3990
About Gelteq Limited Ordinary Shares
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| WYNNE Paul Michael | 0 | — | 2026-03-18 | |
| Szewach Simon H | 0 | — | 2026-03-18 | |
| Szewach Simon H | 65,000 | $2.00 | 2026-03-18 | |
| Karp Bradley Glenn | 0 | — | 2026-03-18 | |
| Givoni Nathan J | 0 | — | 2026-03-18 |